Pfizer-White House deal prompts pharma rally on Wall Streetnews2025-10-01T19:48:48+00:00October 1st, 2025|Endpoints News|
Biogen owes Genentech $88M in royalties from Tysabri, court rulesnews2025-10-01T19:24:10+00:00October 1st, 2025|Endpoints News|
Appeals court rejects Novartis’ attempt to block Entresto genericsnews2025-09-26T18:28:20+00:00September 26th, 2025|Endpoints News|
Novartis escalates court fight against Maine 340B law news2025-09-25T19:02:51+00:00September 25th, 2025|Endpoints News|
AstraZeneca files to try to bring IRA fight to Supreme Court news2025-09-24T19:25:34+00:00September 24th, 2025|Endpoints News|
Arcturus sues AbbVie over Capstan-related trade secrets claimnews2025-09-24T18:43:11+00:00September 24th, 2025|Endpoints News|
Short-term government spending bill includes OTC drug user feesnews2025-09-16T20:01:26+00:00September 16th, 2025|Endpoints News|
AbbVie loses appeal over Mississippi 340B state lawnews2025-09-15T19:00:34+00:00September 15th, 2025|Endpoints News|
Lilly loses bid to overturn $183.7M judgment in Medicaid rebate fightnews2025-09-12T15:59:58+00:00September 12th, 2025|Endpoints News|
AbbVie staves off Rinvoq generics until 2037news2025-09-11T19:11:19+00:00September 11th, 2025|Endpoints News|
